Interaction study reports with reteplase and medicinal product commonly administered in patients with acute myocardial infarction are not available. Heparin, vitamin K antagonists and medicinal product that alter platelet function (such as acetylsalicylic acid, dipyridamole and abciximab) may increase the risk of bleeding if administered prior to, during or after reteplase therapy.